These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8095465)

  • 1. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
    Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T
    Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses.
    Bagdy G; Makara GB
    Endocrinology; 1994 Mar; 134(3):1127-31. PubMed ID: 8119151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects.
    Schmidt BH; Chaouloff F
    Psychoneuroendocrinology; 1993; 18(7):457-66. PubMed ID: 7903466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?
    Broqua P; Laude D; Bluet-Pajot MT; Schmidt B; Baudrie V; Chaouloff F
    Neuroendocrinology; 1993 Apr; 57(4):640-7. PubMed ID: 7690117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect.
    Xu L; Anwyl R; De Vry J; Rowan MJ
    Eur J Pharmacol; 1997 Mar; 323(1):59-68. PubMed ID: 9105877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the involvement of 5-HT1A receptors in the anticonflict effect of ipsapirone in rats.
    Chojnacka-Wójcik E; Przegaliński E
    Neuropharmacology; 1991 Jul; 30(7):703-9. PubMed ID: 1681448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
    Takao K; Nagatani T; Kitamura Y; Yamawaki S
    Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI.
    Levy AD; Li Q; Alvarez Sanz MC; Rittenhouse PA; Brownfield MS; Van de Kar LD
    Eur J Pharmacol; 1992 Oct; 221(1):121-7. PubMed ID: 1333968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses.
    Bagdy G
    Behav Brain Res; 1996; 73(1-2):277-80. PubMed ID: 8788518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear.
    Rittenhouse PA; Bakkum EA; O'Connor PA; Carnes M; Bethea CL; van de Kar LD
    Brain Res; 1992 May; 580(1-2):205-14. PubMed ID: 1354556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses.
    Zamfir O; Broqua P; Baudrie V; Chaouloff F
    Eur J Pharmacol; 1992 Aug; 219(2):261-9. PubMed ID: 1385172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats.
    Li Q; Brownfield MS; Levy AD; Battaglia G; Cabrera TM; Van de Kar LD
    Biol Psychiatry; 1994 Sep; 36(5):300-8. PubMed ID: 7993956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.